Congenital Heart Disease — Ventricular Septal Defect

Embryologic Basis

• Abnormal migration of the conotruncal septum and endocardial cushion tissue during weeks 4-7 of gestation results in incomplete septation of the ventricular chamber
• Four anatomic types correspond to defects in different regions: perimembranous (70-80%), muscular (5-20%), outlet/doubly-committed subarterial (10-30%, highest spontaneous closure), and inlet/endocardial cushion (10-15%) defects
• Molecular abnormalities in NKX2.5, GATA4, and TBX5 transcription factors impair cardiogenic differentiation; 22q11 microdeletion (DiGeorge syndrome) accounts for ~10% of VSDs

Hemodynamic Consequences of Left-to-Right Shunt

• Direction and magnitude of shunt determined by: defect size, relative ventricular and atrial compliance, systemic vascular resistance (SVR), and pulmonary vascular resistance (PVR)
• In acyanotic VSDs, blood shunts left-to-right due to left ventricular pressure exceeding right ventricular pressure; Qp:Qs ratio (pulmonary-to-systemic blood flow) quantifies shunt severity: <1.5:1 (small), 1.5-2.2:1 (moderate), >2.2:1 (large)
• Large defects cause volume overload of left atrium and left ventricle, increasing preload and stroke volume; pulmonary circulation receives excessive blood flow (pulmonary hyperemia), increasing pulmonary vascular workload
• Chronic elevation of PVR from years of high pulmonary blood flow causes progressive pulmonary vascular remodeling: intimal hyperplasia, medial hypertrophy, fibrosis, and arteriolar obliteration, eventually leading to Eisenmenger syndrome (fixed pulmonary hypertension with right-to-left shunt reversal and cyanosis) if not surgically corrected

Secondary Cardiac Changes

• Left ventricular hypertrophy and eccentric remodeling develop from chronic volume overload
• Atrial septal remodeling and dilatation increase risk of atrial arrhythmias
• Pulmonary valve regurgitation may develop secondary to pulmonary hypertension

Chromosomal and Genetic Abnormalities

• 22q11 microdeletion (DiGeorge/velocardiofacial syndrome) — most common syndromic association; accounts for ~10% of VSDs
• Trisomy 21 (Down syndrome) — ~50% have congenital heart disease, 40-45% of those have atrioventricular canal defects or muscular VSDs
• Trisomy 18 (Edwards syndrome) and Trisomy 13 (Patau syndrome) — frequent cardiac involvement
• Turner syndrome (45,X) — increased risk of bicuspid aortic valve and coarctation; VSDs less common
• Single gene mutations in NKX2.5, GATA4, ACTC1 (actin)

Maternal Risk Factors

• Maternal diabetes — 2-4 fold increased risk; hyperglycemia impairs neural crest cell migration
• Maternal rubella infection (first trimester) — causes fetal rubella syndrome with PDA, peripheral pulmonary stenosis, and VSDs
• Maternal alcohol use (fetal alcohol spectrum disorder) — causes septal defects alongside microcephaly, developmental delay
• Maternal phenytoin/anticonvulsant exposure — fetal hydantoin syndrome
• Maternal lithium exposure (first trimester) — increased risk of Ebstein anomaly and other lesions

Multifactorial (Gene × Environment)

• Spontaneous mutations and developmental field defects affect multiple cardiac structures in ~25% of cases
• Familial clustering occurs but inheritance is incomplete and heterogeneous

Symptoms (Highly Size-Dependent)

Small VSDs

• Often asymptomatic, detected incidentally on routine examination or echocardiography
• May have mild exercise intolerance only with large shunts or pulmonary hypertension

Moderate to Large VSDs (presenting in infancy)

• Failure to thrive — poor weight gain and developmental delay from increased metabolic demands of high cardiac output and respiratory effort
• Dyspnea and tachypnea — from pulmonary edema and hyperinflation; manifests as feeding difficulties, wheezing, recurrent respiratory infections
• Fatigue and exercise intolerance — decreased cardiac reserve
• Irritability and poor feeding in neonates

Advanced Disease (Eisenmenger Syndrome)

• Cyanosis — blue discoloration of lips, nail beds, mucous membranes from right-to-left shunting after PVR exceeds SVR
• Dyspnea on exertion, syncope, chest pain
• Clubbing of digits — chronic hypoxemia causes capillary proliferation and hypertrophic osteoarthropathy
• Squatting behavior — increases SVR temporarily to reduce shunt fraction and improve systemic oxygenation (seen in older children with cyanotic lesions)

Physical Examination Findings

Cardiovascular

• Hyperdynamic precordium — palpable systolic thrill at left lower sternal border (4th-5th intercostal space) from turbulent shunt flow; thrill indicates significant shunt
• Holosystolic (pansystolic) murmur — harsh, high-pitched at left lower sternal border radiating to axilla; best heard with patient sitting upright and leaning forward; intensity does NOT correlate with defect size; small restrictive defects may have loud murmurs (high-velocity jet), while large unrestricted defects may have soft murmurs (low velocity)
• Wide, fixed splitting of S2 — due to prolonged right ventricular ejection from volume overload and delayed pulmonary valve closure; "fixed" splitting (minimal respiratory variation) distinguishes from normal physiologic splitting
• Diastolic flow murmur across mitral valve — from increased mitral inflow in left ventricle (relative mitral stenosis)
• Diastolic murmur at left upper sternal border — pulmonary regurgitation from pulmonary hypertension
• Bounding peripheral pulses and wide pulse pressure — from increased stroke volume and decreased peripheral resistance

Non-Cardiac

• Growth retardation — weight <5th percentile, poor linear growth
• Hepatomegaly — from right ventricular failure and hepatic congestion
• Signs of pulmonary edema — crackles at lung bases, increased work of breathing, nasal flaring, intercostal retractions in infants
• Cyanosis (only in Eisenmenger syndrome or if concurrent right-to-left lesion)

Clinical History and Examination

• Detailed prenatal history, maternal risk factors, and family history of congenital heart disease or genetic syndromes
• Symptom timeline: asymptomatic versus failure to thrive, feeding difficulties, respiratory symptoms
• Physical examination as detailed above; presence and character of cardiac murmur

Electrocardiography (ECG)

• Small VSDs: normal or nonspecific changes
• Moderate to large VSDs: left ventricular hypertrophy (LVH) with increased QRS voltage in lateral leads (V5-V6) and ST-T wave changes
• Left atrial enlargement: biphasic P wave in V1 ("P mitrale"), prolonged P wave duration in lead II
• Right ventricular hypertrophy (RVH) patterns (right axis deviation, tall R in V1) develop if Eisenmenger syndrome or significant pulmonary hypertension present
• First-degree AV block common due to proximity of the AV node to membranous VSDs; more significant conduction abnormalities suggest associated endocardial cushion defect

Chest X-Ray (CXR)

• Small VSDs: normal heart size and pulmonary vascularity
• Moderate VSDs: cardiomegaly (cardiothoracic ratio >0.5) with pulmonary vascular congestion ("shaggy" heart borders, indistinct pulmonary arteries, increased pulmonary markings, Kerley B lines at lung bases)
• Large VSDs with Eisenmenger syndrome: ↑ central pulmonary artery size with "pruning" of peripheral vessels (decreased peripheral pulmonary markings); right atrial and right ventricular enlargement
• Pulmonary edema in decompensated infants: diffuse infiltrates, hyperinflation

Echocardiography (Definitive Test)

• Two-dimensional (2D) imaging: directly visualizes the septal defect in multiple planes (apical 4-chamber, parasternal long and short axis, subcostal); identifies anatomic type and location; assesses chamber sizes and ventricular function
• Doppler echocardiography:
• Color-flow Doppler shows the shunt jet (blue for left-to-right flow) crossing the interventricular septum; jet width and length estimate defect size
• Continuous-wave Doppler measures peak velocity of shunt flow; pressure gradient = 4(V)² (modified Bernoulli equation); gradient reflects SVR-PVR relationship; high gradient indicates high PVR or small restrictive defect
• PVR calculation: (TR velocity/VTI ratio) or direct measurement from color Doppler
• Chamber quantification: left ventricular end-diastolic dimension (LVEDD), shortening fraction, ejection fraction; left atrial size; right ventricular size assessment
• Associated defects: screens for patent ductus arteriosus, atrial septal defect, aortic regurgitation (jet into VSD from aortic cusp prolapse — occurs in ~5% of outlet VSDs)
• Qp:Qs calculation: derived from Doppler flow measurements in pulmonary artery and left ventricular outflow tract

Echocardiography distinguishes

• Hemodynamically insignificant VSD — Qp:Qs <1.5:1, small jet, normal chambers, normal PVR
• Hemodynamically significant VSD — Qp:Qs 1.5-2.2:1 or >2.2:1, moderate-to-large jet, left atrial/ventricular dilatation, elevated PA pressure
• Small restrictive VSD — high-velocity jet (high gradient), implies small defect with muscular tissue limiting flow

Cardiac Catheterization (Selective Use)

• Indicated when: diagnosis unclear from echocardiography, need to quantify Qp:Qs in older children, assess PVR before surgery, evaluate for Eisenmenger syndrome
• Findings: step-up in oxygen saturation from right atrium → right ventricle (diagnostic of left-to-right shunt); elevated PA pressures; reduced PVR post-oxygen (suggests reversible PVR elevation); Qp:Qs ratio
• Reversibility testing: inhaled oxygen, nitric oxide to assess PVR reactivity; PVR reduction >20% suggests operability despite elevated baseline
• Angiography: selective left ventricular angiography opacifies defect with contrast spillage into right ventricle

Diagnostic Criteria for Severity

Medical Management (Temporary Measure; Not Curative)

First-Line Pharmacotherapy

• ACE inhibitors (captopril, enalapril) — reduce SVR and afterload, improving cardiac efficiency and reducing shunt magnitude; decrease LV remodeling; particularly effective in large VSDs with left-sided volume overload; typical dose: captopril 0.5-1 mg/kg/dose TID
• Diuretics (furosemide, chlorothiazide) — reduce pulmonary and systemic venous congestion by decreasing preload; loop diuretics preferred for acute decompensation (IV furosemide 1-2 mg/kg IV/PO BID-TID); thiazides for chronic management; combined with spironolactone (aldosterone antagonist) to prevent hypokalemia and support LV remodeling prevention
• Digoxin — positive inotropic effect improves cardiac contractility and reduces elevated venous pressures; less commonly used due to narrow therapeutic window; dose monitoring essential in renal impairment
• Beta-blockers — consider in older children with LV dysfunction or arrhythmias; NOT first-line given potential risk of worsening heart failure in some infants

• Inhaled nitric oxide (NO) — selective pulmonary vasodilator used in perioperative period or ICU management; reduces PVR without systemic hypotension; typical dose 20-40 ppm; particularly useful in patients with elevated PVR
• Phosphodiesterase-5 inhibitors (sildenafil) — pulmonary selective vasodilators for chronic management of elevated PVR; delays progression to Eisenmenger syndrome; dose: sildenafil 0.3-0.6 mg/kg TID

Adjunctive Medical Measures

• Antibiotic prophylaxis for SBE — no longer universally recommended; currently advised only for high-risk lesions (complex cyanotic disease, prosthetic material) for dental procedures and invasive interventions per 2007 AHA guidelines
• Iron supplementation — for microcytic anemia in cyanotic patients; avoid iron overload
• Phlebotomy — for symptomatic polycythemia (hematocrit >65%, symptoms of hyperviscosity); target modest anemia to improve rheology
• NSAIDs contraindicated — risk of patent ductus arteriosus (PDA) closure complications; inhibit prostaglandins necessary for compensatory mechanisms

Surgical Management (Definitive Treatment for Significant Defects)

Indications for Surgical Closure

• Large VSDs with hemodynamic compromise — Qp:Qs >2.2:1, signs of congestive heart failure refractory to medical therapy, failure to thrive despite optimization
• Moderate VSDs unresponsive to medical management — persistent pulmonary vascular congestion, recurrent respiratory infections after 3-6 months of medical therapy
• All VSDs with Eisenmenger syndrome contraindicated — operative mortality high; management becomes medical (see Complications section)
• Timing considerations: infants <6 months with symptomatic large VSDs typically require surgery; small asymptomatic defects followed expectantly; outlet VSDs closed earlier due to risk of aortic regurgitation
• Inlet/endocardial cushion VSDs — often closed contemporaneously with repair of

Complications of the untreated defect

• Eisenmenger syndrome: years of high pulmonary flow drive irreversible arteriolar remodeling until PVR exceeds SVR and the shunt reverses. Signaled by disappearance of the holosystolic murmur (flow equalizes across the defect), a loud single P2, new cyanosis and clubbing, and erythrocytosis. Per the AHA/ACC adult congenital heart disease guideline this converts an operable lesion into an inoperable one — closure removes the pop-off valve and precipitates fatal RV failure.
• Congestive heart failure and failure to thrive in infancy: volume overload once PVR falls at roughly 4–8 weeks of life. Tachypnea with feeds, diaphoresis, hepatomegaly, and weight crossing percentiles downward are the signals.
• Infective endocarditis: the high-velocity jet injures the RV septal surface and tricuspid apparatus, creating a nidus. New fever plus a changing murmur or embolic phenomena warrants blood cultures and echocardiography — an emergency if heart block, abscess, or septic emboli are present.
• Aortic regurgitation: Venturi effect on an unsupported right or non-coronary cusp adjacent to an outlet or perimembranous defect causes cusp prolapse; a new early diastolic decrescendo murmur mandates repair even if the shunt is small.
• Paradoxical embolism, stroke, and brain abscess: once shunting is right-to-left, venous debris bypasses the pulmonary filter. Focal deficit or fever plus headache in a cyanotic patient is an emergency requiring urgent neuroimaging; meticulous IV air filters are mandatory.
• Hyperviscosity, hemoptysis, arrhythmia: secondary erythrocytosis, pulmonary artery thrombosis, and atrial arrhythmias complicate late Eisenmenger physiology. Massive hemoptysis is an emergency.

Complications of treatment

• Complete heart block: the AV node and His bundle run along the posteroinferior rim of perimembranous defects; surgical suture or device radial force can injure them. Bradycardia with AV dissociation is an emergency — pacing is required.
• Residual shunt, device embolization, tricuspid regurgitation, and postoperative RBBB: detected by follow-up echocardiography.
• Postoperative pulmonary hypertensive crisis: an emergency treated with oxygen, sedation, and inhaled nitric oxide.

• The murmur is inversely related to defect size: a harsh holosystolic murmur with a palpable thrill at the left lower sternal border means a small, restrictive defect maintaining a large LV–RV pressure gradient. A large unrestrictive defect gives a soft murmur with a sick-looking infant — softness is not reassurance.
• Timing of presentation is a favorite stem detail: an infant with a large VSD is often quiet at birth and declares itself at several weeks of age, when physiologic PVR falls and the left-to-right shunt increases.
• Single best next step for a suspected VSD is transthoracic echocardiography with color Doppler — it defines location, Qp:Qs, chamber size, and PA pressure. Catheterization is reserved for quantifying PVR and reversibility when operability is in question.
• The one association examiners test is Eisenmenger syndrome. Cyanosis, clubbing, erythrocytosis, and a vanishing murmur in a previously acyanotic patient means shunt reversal; per the AHA/ACC adult congenital heart disease guideline the defect is then no longer closable, and pregnancy carries prohibitive maternal mortality (ACOG and AHA classify it as a contraindication).
• Genetics: think 22q11.2 microdeletion with conotruncal/outlet defects, hypocalcemia, and thymic aplasia; think trisomy 21 with inlet/AV canal defects.
• Endocarditis prophylaxis: the 2007 AHA guidance does not recommend it for an isolated unrepaired VSD. It applies for the first six months after repair with prosthetic material, or indefinitely if a residual defect sits adjacent to the patch.
• Common distractors to avoid: squatting and hypercyanotic spells belong to tetralogy of Fallot, not to an isolated VSD; differential cyanosis (pink upper body, blue lower) points to a PDA with reversed shunt; and in an adult, a new holosystolic murmur with thrill several days after an inferior or anterior MI is a post-infarction septal rupture requiring emergent surgical evaluation, not a congenital VSD.